Bridgebio Pharma, Inc. · NASDAQ:BBIO

Aguiar Eric received 3,990 Bridgebio Pharma, Inc. shares as an award (Form 4)

Traded Jun 22, 2026 · Filed Jun 24, 2026

On Jun 22, 2026, Aguiar Eric (Director) received 3,990 Bridgebio Pharma, Inc. shares as an award, leaving 10,579 shares. Filed Jun 24, 2026 (Form 4).

Awarded
3,990 shares
Holding after
10,579 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockAward3,99010,579Direct

Source

View original at SEC

Related